When will Compass Pathways submit a NDA for COMP360 psilocybin?
Prediction market on kalshi. If COMPASS Pathways plc submits a NDA for COMP360 psilocybin to the FDA before Nov 1, 2026, then the market resolves to Yes.
Liquidity: $355.13. Resolves: 11/8/2026.